Characterizing spatiotemporal white matter hyperintensity pathophysiology in vivo to disentangle vascular and neurodegenerative contributions
Year: 2026
Type: article
Study design: Observational Study
Abstract: White matter hyperintensities (WMHs) are neuroimaging markers widely interpreted as caused by cerebral small vessel disease, yet emerging evidence suggests that a subset may have a neurodegenerative etiology. Current imaging methods have lacked the specificity to disentangle biological processes underlying WMHs in vivo. Here, we used voxel-level normative modeling and seven microstructural MRI markers with complementary biophysical sensitivities to generate single-subject high-resolution WMH pathophysiology maps in a large cohort (n = 32,526). We calculated data-driven spatial patterns of similar WMHs, revealing distinct periventricular, posterior, and anterior clusters. We identified a reproducible WMH signature linked to dementia and Alzheimer's disease, characterized by a posterior predominance and a pathophysiological pattern indicative of selective fiber degeneration. Posterior WMHs connected cortical regions vulnerable to tau pathology. Our framework helps parsing vascular and neurodegenerative contributions of WMHs in vivo, which could alter the course of treatment strategies and provide nuanced interpretations of research findings.
Source: Nature Communications
Authors: Olivier Parent, Zaki Alasmar, Sophia Osborne, Aurélie Bussy, Manuela Costantino, Jérémie P. Fouquet, Daniela Quesada, Alexandre Pastor-Bernier, Alfonso Fajardo-Valdez, Alexa Pichet-Binette, Ann McQuarrie, Josefina Maranzano, Gabriel A. Devenyi, Christopher J. Steele, Sylvia Villeneuve, the Alzheimer’s Disease Neuroimaging Initiative (ADNI), Mahsa Dadar, M. Mallar Chakravarty
Institutions: Douglas Mental Health University Institute, McGill University, Canadian Sleep & Circadian Network, Université de Montréal, Institut Universitaire de Gériatrie de Montréal, Université du Québec à Trois-Rivières, Max Planck Institute for Human Cognitive and Brain Sciences, Concordia University, Montreal Neurological Institute and Hospital
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $6,990
Funders: Pfizer, McGill University, Fondation Brain Canada, Canadian Bee Research Fund, Government of Canada, Alzheimer Society, Canada First Research Excellence Fund, Alliance de recherche numérique du Canada, Pfizer Canada, Canadian Institutes of Health Research, Fonds de Recherche du Québec - Santé
OpenAlex ID: W7143945179
